Tobii Dynavox AB (publ) (TDVXF) Stock Price, News & Analysis

Company Overview

Tobii Dynavox AB (publ) is a Sweden-based assistive technology company specializing in augmentative and alternative communication (AAC) solutions for individuals with speech and language disabilities. The company develops and markets speech-generating devices, eye-tracking communication systems and companion software designed to facilitate expressive communication, literacy development and educational integration. Its product portfolio includes tools such as the I-110 speech device, Indi communication tablet, EyeMobile Mini eye-tracker and proprietary software platforms like Snap Core First and TD Snap, which support symbol- and text-based communication.

Originally founded as DynaVox Systems in the United States in the early 1980s, the business became part of the Tobii Group following a strategic acquisition in 2014. Since that time, Tobii Dynavox has leveraged Tobii’s eye-tracking and human-computer interaction expertise to enhance its assistive hardware and software offerings. The company serves customers across North America, Europe, Asia-Pacific and other global markets, partnering with rehabilitation professionals, educators and caregivers to deliver tailored AAC solutions. It also provides training, support and online resources to ensure effective implementation in clinical, home and school settings.

Headquartered in Danderyd, Sweden, Tobii Dynavox operates under the broader Tobii AB corporate structure while maintaining dedicated research and development, manufacturing and customer service teams. Its leadership team comprises industry veterans in assistive technology and speech pathology, supported by a global network of specialists who focus on product innovation, regulatory compliance and customer success. Through ongoing collaboration with healthcare institutions and academic centers, Tobii Dynavox continues to advance communication access for individuals with complex needs worldwide.

Key Stats

• Today's Range: $7.90 to $7.90
• 50-Day Range: $7.90 to $10.40
• 52-Week Range: $7.90 to $13.55
• Volume: 565 shs
• Average Volume: 1,005 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 5/19/2026
• Next Earnings (Estimated): 7/22/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:TDVXF
• CIK: N/A
• Web: www.tobiidynavox.com
• Phone: 46-8-522-950-20
• Fax: N/A
• Employees: 722
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A